Colon cancer: Changes in gut bacteria may lead to new blood test


Clinical Gastroenterology Journal  is a peer reviewed, open access journal considering submissions on topics covering on all aspects of digestive system, gastrointestinal diseases, liver, bilary tract, pancreas, diseases of related organs Ulcer medicine, Colitis, Diverticulitis and associated disorders and their treatment. 

Research in mice and humans suggests that imbalances in gut bacteria could play a key role in promoting the development of colorectal cancer. The finding is helping researchers develop a blood test that may help them diagnose this form of cancer.

In 2019, doctors will have diagnosed an estimated 145,600 new cases of colorectal cancer in the United States alone, according to the National Cancer Institute. his form of cancer has no obvious symptoms in its initial stages, which can make it hard to diagnose early on. This may mean that individuals do not have the opportunity to start the appropriate treatment before the tumors have grown and spread.

Matters become even more complicated in the case of sporadic colorectal cancer, which develops in people with no known risk factors for cancer.

For these reasons, researchers are continually looking for better ways of understanding both what drives colorectal cancer risk, and how to identify its presence early on.

This finding has helped the investigators develop a blood test able to pick up on the epigenetic (gene expression) changes that, in turn, are associated with both dysbiosis and tumor development.

The Clinical Gastroenterology Journal is helping to spread awareness by inviting Eminent Researchers to Share their Knowledge with the people globally by submitting their valuable Research work to our journal, which is globally accessed by millions of readers which spreads awareness.

During this year we look forward to taking some initiatives that would encourage and reward our prospective audience which include clinicians, research scientists, decision-makers and a range of professionals in the Clinical Gastroenterology.

It gives us great pleasure to invite Prospective academicians and scientists and encouraged to utilize this opportunity to get their articles reviewed, processed and published at relatively faster pace and at lower charges.

The Journal accepts original manuscripts in the form of Research articles, Review articles, Clinical reviews, Commentaries, Case reports, Perspectives and Short communications encompassing all aspects of Clinical Gastroenterology and Hepatology for publication in open access platform.

All the manuscript published by Clinical Gastroenterology Journal are available freely online immediately after publication without any subscription charges or registration.

If your manuscript is ready you can submit it directly online: or as an attachment to this E-mail:

How we work:

• After submission, an acknowledgement with manuscript number is sent to the corresponding author within 7 working days.
• A 21-day window time frame is allotted for peer-review process wherein multiple experts are contacted.
• Author proof is generated within 7 working days after the acceptance decision.

Benefits on Publication: Open Access: Permanent free access to your article upon publication ensures extensive global reach and readership.

Social Media Exposure: Extended reach for your article through links on Twitter accounts provides maximum visibility worldwide. Follow us on twitter for latest updates regarding Gastroenterology at:

Reprints: Distribute your work to colleagues and at conferences as we provide hard copy color reprints of your article on order.

Media Contact:
Jessica Watson
Journal Manager
Clinical Gastroenterology Journal
WhatsApp: +1-947-333-4405